Candel Therapeutics (CADL) Treasury Shares (2020 - 2025)
Candel Therapeutics (CADL) posted Treasury Shares of $448000.0 for Q4 2025, little changed sequentially from $448000.0 in Q3 2025, and little changed YoY from $448000.0 in Q4 2024.
Candel Therapeutics (CADL) Treasury Shares (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Treasury Shares for 4 years, with the latest figure at $448000.0 in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $448000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $448000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $448000.0, changed 0.0% from the prior year.
- Treasury Shares steadied at $448000.0 in Q4 2025 per CADL's latest filing, from $448000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $6.0 million in Q1 2021 and troughed at -$122608.0 in Q4 2023.
- A 5-year average of $1.4 million and a median of $612366.0 in 2022 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 0.0% in 2023, down 0.0% in 2023.
- Over 4 years, Treasury Shares stood at $448000.0 in 2022, then changed by 0.0% to $448000.0 in 2023, then changed by 0.0% to $448000.0 in 2024, then changed by 0.0% to $448000.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $448000.0, $448000.0, and $448000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | 448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 448,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Dec 31, 2025 | -122,608.00 |
| Dec 31, 2025 | -122,608.00 |
| Sep 30, 2025 | -122,608.00 |
| Sep 30, 2025 | -122,608.00 |
| Sep 30, 2025 | 448,000.00 |
| Sep 30, 2025 | 448,000.00 |
| Jun 30, 2025 | -122,608.00 |
| Jun 30, 2025 | -122,608.00 |
| Jun 30, 2025 | 448,000.00 |
| Jun 30, 2025 | 448,000.00 |
| Mar 31, 2025 | 448,000.00 |
| Mar 31, 2025 | 448,000.00 |
| Mar 31, 2025 | -122,608.00 |
| Mar 31, 2025 | -122,608.00 |
| Dec 31, 2024 | 448,000.00 |
| Dec 31, 2024 | 448,000.00 |
| Dec 31, 2024 | 330,779.00 |
| Dec 31, 2024 | 330,779.00 |